Intellectia LogoIntellectia
Product
Resources
Markets
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns
Daytrading Center

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks
Pricing
Start for Free
  1. Home
  2. >
  3. Stock
  4. >
  5. HCA
stocks logo

HCA

-
Add to WatchlistAdvanced Chart
$
0.000
0.000(0.000%)
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q2
FY2025Q3
FY2025Q4
18.49B
+5.68%
6.270
+14%
18.49B
+5.71%
5.553
+13.33%
19.38B
+5.97%
7.182
+15.46%
Estimates Revision
The market is revising Upward the revenue expectations for HCA Healthcare, Inc. (HCA) for FY2025, with the revenue forecasts being adjusted by 0.11% over the past three months. During the same period, the stock price has changed by 13.08%.
Revenue Estimates for FY2025
Revise Upward
up Image
+0.11%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
up Image
+1.77%
In Past 3 Month
Stock Price
Go Up
up Image
+13.08%
In Past 3 Month
12 Analyst Rating
up Image0
Wall Street analysts forecast HCA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HCA is 390.80 USD with a low forecast of 336.00 USD and a high forecast of 444.00  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
8 Buy
4 Hold
0 Sell
Moderate Buy
up Image0
Current: 377.500
sliders
Low
336.00
Averages
390.80
High
444.00
up Image0
Current: 377.500
sliders
Low
336.00
Averages
390.80
High
444.00
Morgan Stanley
Craig Hettenbach
Equal Weight
maintain
$355 -> $410
2025-06-09
Reason
Morgan Stanley
Craig Hettenbach
Price Target
$355 -> $410
2025-06-09
maintain
Equal Weight
Reason
Morgan Stanley analyst Craig Hettenbach raised the firm's price target on HCA Healthcare (HCA) to $410 from $355 and keeps an Equal Weight rating on the shares. HCA's scale and operating initiatives underpin consistently strong margins, says the analyst, who adds that higher margins and lower capital intensity should drive multiple expansion in Tenet Healthcare (THC) and narrow the gap to HCA. Given that view, the analyst calls out Tenet as the firm's preferred stock in hospitals.
Barclays
Andrew Mok
Overweight
maintain
$366 -> $416
2025-06-02
Reason
Barclays
Andrew Mok
Price Target
$366 -> $416
2025-06-02
maintain
Overweight
Reason
Barclays analyst Andrew Mok raised the firm's price target on HCA Healthcare to $416 from $366 and keeps an Overweight rating on the shares. Following Q1 earnings and "several negative data points" around Part D mix, Affordable Care Act trend, and preliminary 2026 ACA rates, the firm is more concerned on the Medicare Part D and individual ACA businesses, which it believes carry negative earnings risk for the balance of 2025 and face significant premium increases and disruption in 2026. With limited prospects of multiple expansion and an unfavorable managed care catalyst calendar, investors are likely to be more sensitive to earnings revisions, which skew negatively for Part D- and ACA-sensitive stocks, the analyst tells investors in a research note. Barclays continues to prefer hospitals to managed care.
Wells Fargo
Underweight -> Equal Weight
upgrade
$385
2025-05-29
Reason
Wells Fargo
Price Target
$385
2025-05-29
upgrade
Underweight -> Equal Weight
Reason
Wells Fargo upgraded HCA Healthcare to Equal Weight from Underweight with a $385 price target.
Wells Fargo
Underweight -> Equal Weight
upgrade
$320 -> $385
2025-05-29
Reason
Wells Fargo
Price Target
$320 -> $385
2025-05-29
upgrade
Underweight -> Equal Weight
Reason
As previously reported, Wells Fargo upgraded HCA Healthcare to Equal Weight from Underweight with a price target of $385, up from $320. The firm is now more constructive on the hospital group and sees policy risks as having receded following the House passage of budget reconciliation legislation. While the legislation will face changes in the Senate and needs to be passed again by the House, Wells believes healthcare spending cuts are unlikely to worsen and could potentially moderate. Although the coverage impacts will be a headwind, the firm thinks they are likely to be manageable.
BofA
Joanna Gajuk
Buy
maintain
$370 -> $410
2025-05-13
Reason
BofA
Joanna Gajuk
Price Target
$370 -> $410
2025-05-13
maintain
Buy
Reason
BofA analyst Joanna Gajuk raised the firm's price target on HCA Healthcare to $410 from $370 and keeps a Buy rating on the shares. The firm hosted a discussion at the BofA Healthcare Conference with HCA CFO Michael Marks, noting that the tone was bullish given underlying strong demand for services and the ability to control costs as evidenced by 11% EBITDA growth in Q1. BofA added that it raised its price target on the shares on a higher multiple to reflect confidence in this year and higher peer multiples, noting that uncertainty on macro, tariffs, and policy changes have not been noticeable.
Baird
Michael Ha
Buy
to
Hold
Downgrades
$396 → $336
2025-04-15
Reason
Baird
Michael Ha
Price Target
$396 → $336
2025-04-15
Downgrades
Buy
to
Hold
Reason
See All Ratings

Valuation Metrics

The current forward P/E ratio for HCA Healthcare Inc (HCA.N) is 14.10, compared to its 5-year average forward P/E of 13.39. For a more detailed relative valuation and DCF analysis to assess HCA Healthcare Inc 's fair value, click here.
    Forward PE
    Forward EV/EBITDA
    Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PE
13.39
Current PE
14.10
Overvalued PE
15.20
Undervalued PE
11.58

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average EV/EBITDA
8.73
Current EV/EBITDA
9.22
Overvalued EV/EBITDA
9.56
Undervalued EV/EBITDA
7.90

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PS
1.11
Current PS
1.19
Overvalued PS
1.28
Undervalued PS
0.95

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

    Insider
    Hedge Fund
    Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress areSelling! The selling amount has increased100%over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought

HCA News & Events

Events Timeline

(ET)
2025-05-02
06:17:13
Billions of dollars of Medicaid payments for hospitals delayed, WSJ reports
select
link
2025-04-25 (ET)
2025-04-25
07:40:19
HCA Healthcare backs FY25 EPS view $24.05-$25.85, consensus $24.96
select
2025-04-25
07:36:54
HCA Healthcare reports Q1 EPS $6.45, consensus $5.75
select
Sign Up For More Events
Sign Up For More Events

News

Preview
3.0
06-19NASDAQ.COM
HCA Factor-Based Stock Analysis
  • HCA Healthcare Inc. Rating: HCA Healthcare Inc. has received a high rating of 93% from Validea's Multi-Factor Investor model, indicating strong interest based on its fundamentals and valuation in the Healthcare Facilities industry.

  • Pim van Vliet's Investment Strategy: The strategy, developed by Pim van Vliet, focuses on low volatility stocks with strong momentum and high net payout yields, highlighting that low volatility stocks can outperform high volatility ones with less risk.

Preview
8.0
06-18MarketWatch
20 companies in the S&P 500 whose investors gained the most from stock buybacks
  • Criticism of Stock Buybacks: Corporate boards face criticism for spending on stock buybacks, which can lower share count and raise earnings per share, but may be wasteful if share prices are high.

  • Impact on Investors: Buybacks may not always benefit investors, especially if new shares are issued to executives, leading to increased share count and diluted earnings per share.

Preview
2.0
06-17Benzinga
HCA Healthcare Climbs 3.6% After Key Trading Signal
  • Power Inflow Signal: HCA Healthcare Inc. experienced a significant Power Inflow at $355.95, indicating potential upward momentum in its stock price, which traders interpret as a bullish signal for future trading opportunities.

  • Importance of Risk Management: While the Power Inflow suggests positive market conditions, it is essential for traders to implement effective risk management strategies to protect their capital and navigate market uncertainties.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is HCA Healthcare Inc (HCA) stock price today?

The current price of HCA is 377.5 USD — it has increased 0.17 % in the last trading day.

arrow icon

What is HCA Healthcare Inc (HCA)'s business?

HCA Healthcare, Inc. is a health care services company. It owns, manages or operates hospitals, ambulatory surgery centers (ASCs), freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, comprehensive rehabilitation and physical therapy centers, hospices, and various other facilities. Its general, acute care hospitals provide a full range of services to accommodate such medical specialties as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics, as well as diagnostic and emergency services. Its behavioral hospitals provide a full range of mental health care services through inpatient, partial hospitalization and outpatient settings. It operates approximately 190 hospitals and 2,400 ambulatory sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics, in 20 states and the United Kingdom.

arrow icon

What is the price predicton of HCA Stock?

Wall Street analysts forecast HCA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HCA is 390.80 USD with a low forecast of 336.00 USD and a high forecast of 444.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is HCA Healthcare Inc (HCA)'s revenue for the last quarter?

HCA Healthcare Inc revenue for the last quarter amounts to 18.32B USD, increased 5.66 % YoY.

arrow icon

What is HCA Healthcare Inc (HCA)'s earnings per share (EPS) for the last quarter?

HCA Healthcare Inc. EPS for the last quarter amounts to 6.45 USD, increased 8.59 % YoY.

arrow icon

What changes have occurred in the market's expectations for HCA Healthcare Inc (HCA)'s fundamentals?

The market is revising Upward the revenue expectations for HCA Healthcare, Inc. (HCA) for FY2025, with the revenue forecasts being adjusted by 0.11% over the past three months. During the same period, the stock price has changed by 13.08%.
arrow icon

How many employees does HCA Healthcare Inc (HCA). have?

HCA Healthcare Inc (HCA) has 226000 emplpoyees as of June 23 2025.

arrow icon

What is HCA Healthcare Inc (HCA) market cap?

Today HCA has the market capitalization of 92.94B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free